You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科倫藥業(002422.SZ):5個藥品首次納入國家醫保目錄
格隆匯 01-19 08:00

格隆匯1月19日丨科倫藥業(002422.SZ)公佈,2023年1月18日,國家醫保局發佈《關於印發<國家基本醫療保險、工傷保險和生育保險藥品目錄(2022年)>的通知》(醫保發〔2023〕5號)。根據該通知,公司的藥品,中長鏈脂肪乳/氨基酸(16)/葡萄糖(36%)注射液、注射用頭孢他啶/5%葡萄糖注射液、舒更葡糖鈉注射液、碳酸氫鈉林格注射液、氨基酸(15)腹膜透析液,經談判、競價首次納入《國家基本醫療保險、工傷保險和生育保險藥品目錄(2022年)》。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account